PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE 250

162.00p
   
  • Change Today:
      0.20p
  • 52 Week High: 237.50p
  • 52 Week Low: 140.40p
  • Currency: UK Pounds
  • Shares Issued: 239.42m
  • Volume: 496,505
  • Market Cap: £387.86m
  • Beta: 0.94

PureTech Health's Vor wins FDA fast-track approval for cancer drug

By Frank Prenesti

Date: Friday 10 Sep 2021

LONDON (ShareCast) - (Sharecast News) - Clinical stage biotherapeutics firm PureTech Health on Friday said its founded entity, Vor Biopharma, had won US fast track approval for its leukaemia treatment.
The US Food and Drug Administration granted the designation to VOR33, a hematopoietic stem cell therapeutic candidate for the treatment of acute myeloid leukaemia.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

PRTC Market Data

Currency UK Pounds
Share Price 162.00p
Change Today 0.20p
% Change 0.12 %
52 Week High 237.50p
52 Week Low 140.40p
Volume 496,505
Shares Issued 239.42m
Market Cap £387.86m
Beta 0.94

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
2.22% below the market average2.22% below the market average2.22% below the market average2.22% below the market average2.22% below the market average
52.00% above the sector average52.00% above the sector average52.00% above the sector average52.00% above the sector average52.00% above the sector average
Price Trend
49.04% below the market average49.04% below the market average49.04% below the market average49.04% below the market average49.04% below the market average
2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average
Income Not Available
Growth
69.3% below the market average69.3% below the market average69.3% below the market average69.3% below the market average69.3% below the market average
70.59% below the sector average70.59% below the sector average70.59% below the sector average70.59% below the sector average70.59% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

PRTC Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:43 3,441 @ 162.00p
16:29 493 @ 162.60p
16:29 17 @ 162.60p
16:29 153 @ 162.60p
16:28 659 @ 162.60p

PRTC Key Personnel

Chair Raju Kucherlapati
CEO Bharatt Chowrira

Top of Page